Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zastaprazan vs Rabeprazole on Platelet Reactivity of Clopidogrel After PCI
NCT07471867Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zastaprazan in Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Yonsei University. Primary endpoint: P2Y12 Reaction Units at 1 month. Started Apr 2026; status: recruiting.
02
Drugs
zastaprazan
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NCT07471867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07471867.